SUN PHARMA ADVANCED RESEARCH COMPANY LTD. Q4 FY25 Results
SPARCQ4 FY25 ResultsAnnounced 19 May 2025, 08:52 pm| Metric | Value (₹ Cr) | vs Q3 FY25 |
|---|---|---|
| Revenue | 27.19 | 82.4% |
| Total Income | 27.19 | 80.1% |
| Expenditure | 87.86 | 7.1% |
| PBT | -60.67 | 23.6% |
| Net Profit | -59.77 | 24.8% |
| OPM | — | |
| NPM | — | |
| EPS | 1.84 | 175.1% |
Informational and educational content only. Not investment advice.